Welcome to the forefront of conversational AI as we explore the fascinating world of AI chatbots in our dedicated blog series. Discover the latest advancements, applications, and strategies that propel the evolution of chatbot technology. From enhancing customer interactions to streamlining business processes, these articles delve into the innovative ways artificial intelligence is shaping the landscape of automated conversational agents. Whether you’re a business owner, developer, or simply intrigued by the future of interactive technology, join us on this journey to unravel the transformative power and endless possibilities of AI chatbots.
The Middle East AI in patient engagement market size was estimated at USD 183.53 million in 2024 and is projected to reach USD 1,110.56 million by 2033, growing at a CAGR of 22.26% from 2025 to 2033. Rapid expansion of digital health infrastructure, coupled with integration of artificial intelligence (AI) in healthcare, growing adoption of telemedicine and remote care, and increasing government investments, are factors contributing to market growth.
Healthcare systems across the Middle East are undergoing rapid digitalization, harnessing AI integration. National healthcare strategies across the Middle East, such as Saudi Arabia’s Vision 2030 and the UAE’s Vision 2031, are significantly accelerating the adoption of AI-driven patient engagement solutions. Governments are investing substantially in AI-powered platforms to support preventive care, chronic disease management, and improved health outcomes. Such initiatives encourage hospitals and private healthcare organizations to align with government objectives, thereby increasing demand for AI-enabled patient engagement solutions.
Investments facilitate the deployment of advanced AI-powered tools, including chatbots, virtual health assistants, and predictive analytics platforms that optimize patient communication and healthcare accessibility. For instance, in April 2025, Scale AI collaborated with the Qatar government to develop AI agents for healthcare. This deal includes developing AI voice, chat, and email agents for contact centers.
Moreover, the rapid adoption of telehealth platforms and remote patient monitoring solutions drives market growth further. Patients are adopting mobile health applications, patient portals, wearable devices, and virtual consultations that empower them to manage their health proactively. For instance, in January 2025, Medinous HMS launched a next-generation patient mobile application simplifying healthcare access and engagement. Features include seamless appointment scheduling for new and registered patients, instant access to medical records, real-time lab and procedure results, secure communication, payment management, insurance status updates, and personalized patient dashboards.
The chart below illustrates the relationship between industry concentration, industry characteristics, and industry participants. The x-axis represents the level of industry concentration, ranging from low to high. The y-axis represents various industry characteristics, including industry competition, level of partnerships & collaboration activities, degree of innovation, impact of regulations, and regional expansion. The degree of innovation and the impact of regulations on industry is moderate to high. However, the level of merger & acquisition activities and the regional expansion of the industry is moderate.
The Middle East AI in patient engagement market experiences a moderate to high degree of innovation, fueled by ongoing digital health transformation initiatives, strong government backing, and increasing consumer expectations for seamless, technology-enabled healthcare experiences. Regional healthcare systems are rapidly adopting AI-powered chatbots, remote monitoring tools, and personalized patient portals to enhance service delivery and improve patient satisfaction.
The industry is experiencing a moderate level of merger and acquisition activities undertaken by several key players. This is due to the desire to gain a competitive advantage in the industry, enhance technological capabilities, and consolidate in a rapidly growing market.
Impact of regulations on the Middle East market is high, as governments across the region implement increasingly robust digital health frameworks to ensure data privacy, interoperability, and patient safety. Regulatory bodies such as the UAE’s Ministry of Health and Prevention (MOHAP) and Saudi Health Council mandate compliance with global standards such as the HIPAA, GDPR, and HL7 FHIR for health information exchange and patient data protection.
The extent of regional market expansion is moderate, propelled by increasing efforts toward healthcare digitization and robust government initiatives within the Gulf Cooperation Council (GCC) countries. As national health systems in the UAE, Saudi Arabia, and Qatar advance toward integrated health information platforms, there is a rising demand for interoperable patient engagement solutions capable of being deployed across multiple healthcare facilities and jurisdictions.
Based on delivery mode type, the cloud-based segment accounted for the largest revenue share of 77.65% in 2024. In addition, this segment is anticipated to grow at the fastest CAGR during the forecast period. Cloud-based platforms enable convenient access to patient engagement solutions from any location with internet connectivity, facilitating remote patient monitoring & management. These platforms support seamless integration with existing healthcare systems and applications. In addition, cloud-based delivery models generally involve lower upfront costs compared to traditional on-premise solutions, as they eliminate the need for expensive hardware infrastructure and ongoing maintenance.
For instance, in September 2024, Exotel launched Saudi Arabia’s first local Customer Experience (CX) cloud integrated with AI and local telephony, enhancing business communications aligned with Vision 2030. The platform offers AI-powered co-pilots and omnichannel support, enabling personalized, real-time customer interactions while ensuring data security and compliance, for multiple industries, including healthcare.
However, the on-premise segment is expected to grow significantly over the forecast period. On-premise solutions allow for greater customization to meet specific organizational needs and preferences, providing flexibility in implementation & configuration. Healthcare providers have full control over their data, ensuring compliance with regulatory requirements and maintaining data privacy & security.
Based on functionality, enhanced communication segment dominated the market with the largest revenue share of 27.05% in 2024, as they address the need for continuous engagement between patients and healthcare providers. Integrating AI chatbots, virtual assistants, and automated messaging systems enhances the patient experience by providing timely updates, reminders, and responses to inquiries. This innovative approach reduces the necessity for in-person visits and ensures that care delivery remains interactive and responsive to patient needs. In addition, enhanced communication tools enable providers to send personalized reminders, educational content, and alerts, keeping patients actively involved in their care plans. These tools reduce missed appointments and medication non-adherence. As healthcare systems emphasize preventive care, communication-driven engagement has become crucial to patient-centered models.
The chatbots and virtual health assistants segment is expected to grow at the fastest CAGR during the forecast period. The adoption of chatbots and virtual health assistants is on the rise, primarily due to their ability to provide continuous support, ensuring that patients can access healthcare information and assistance anytime. Healthcare providers in the Middle East are navigating the challenges of reducing operational costs while simultaneously working to expand access to care. Chatbots and virtual assistants automate routine interactions such as appointment scheduling, prescription reminders, and basic triage, reducing administrative burdens on staff. This allows healthcare professionals to focus on complex cases while AI handles repetitive tasks efficiently. The cost savings, combined with improved workflow efficiency, are driving investment in this segment.
Based on technology, the NLP segment accounted for the largest revenue share of 89.76% in 2024. NLP models enhance patient engagement and education by delivering personalized, easily understandable health information. By analyzing patient-generated data, such as social media posts and online forums, NLP identifies patient needs, concerns, & preferences. This enables healthcare providers to deliver personalized educational materials, improve communication, and foster shared decision-making. By leveraging predictive analytics and NLP, smart assistance technologies improve patient satisfaction, streamline healthcare processes, and enable proactive management of patient needs.
Others segment is expected to grow significantly over the forecast period. The others segment includes computer vision, machine learning technologies, etc. These advanced technologies have a wide range of applications across healthcare settings, contributing to improved patient outcomes and enhanced operational efficiency. Computer vision enables the analysis of medical images, facilitating early disease detection and diagnosis.
Based on therapeutic area, chronic disease management segment dominated the market, with the largest share of 65.31% in 2024. Artificial intelligence technologies are integral in this domain, offering predictive analytics, tailored care strategies, and continuous monitoring to enable healthcare professionals to manage and engage patients suffering from chronic conditions more effectively. For instance, in February 2025, Lillia, a Qatar-based startup, unveiled an AI-powered platform for chronic disease management, focusing on diabetes and related conditions. The platform combines AI with expert human coaches, offering personalized care tailored to an individual’s metabolism and lifestyle.
The health and wellness segment is expected to grow at the fastest CAGR over the forecast period. With the increasing focus on preventive care and personalized health management, AI technologies are being leveraged to enhance patient engagement in this sector. Incorporating AI in this domain aligns with the ongoing trend of leveraging multimodal AI models that integrate images, videos, and numerical data to enable a more patient-centric approach in healthcare, thereby driving significant market expansion.
The healthcare providers segment dominated the market, with the largest share of 39.22% in 2024. Healthcare providers’ increasing adoption of AI in patient engagement is driven by multiple factors, including a heightened focus on patient-centric care, the imperative for optimized resource allocation, and the expanding demand for tailored healthcare experiences.
For instance, in April 2025, Almoosa Health in Saudi Arabia deployed Salesforce Health Cloud and Marketing Cloud to enhance patient communication, engagement, and operational efficiency. The AI-powered platform integrates channels like face-to-face, WhatsApp, email, and calls to provide seamless patient experiences, reduce no-shows, deliver personalized lifestyle recommendations, and support healthcare goals aligned with Vision 2030.
“As an internationally recognized healthcare provider, we are excited to deploy state-of-the-art AI-powered solutions from Salesforce to deliver the best possible engagement and health services for our patients, while maximizing efficiencies across the group.”
–Malek Abdulaziz Almoosa, CEO of Almoosa Health
The pharmaceutical companies’ segment is projected to grow at the fastest CAGR from 2025 to 2033. AI-powered engagement platforms allow these companies to interact directly with patients, offering education, adherence support, and disease management tools. Chatbots and digital assistants help recruit, educate, and retain patients in trials by providing timely information and reminders. AI also enables the collection of real-world evidence by monitoring patient behavior and treatment responses post-commercialization.
Saudi Arabia AI in patient engagement market held the largest market share or 39.80% in 2024. Rising smartphone penetration, adoption of teleconsultation services with physicians, and the growing number of users of digital applications such as Seha, Tawakkalna, and Tabaud, which provide telehealth services in the country, boost the market growth.
Moreover, government initiatives to promote rapid AI technology adoption significantly boost the Saudi Arabia patient engagement solutions market. For instance, in May 2024, Saudi government officials highlighted the country’s transformative shift toward AI during a session at the World Economic Forum in Riyadh.
The UAE AI in patient engagement market is anticipated to grow at the fastest CAGR during the forecast period. The integration of technology into healthcare systems is a significant driver of the patient engagement market in the UAE. Moreover, rising government support and strategic initiatives undertaken by leading companies to increase awareness of the use of AI solutions in the healthcare industry further fuel market growth.
Key players operating in the Middle East AI in patient engagement market are undertaking various initiatives to strengthen their market presence and increase the reach of their products and services. Strategies such as new product launches and partnerships play a key role in propelling market growth.
In July 2025, Neyox.ai launched intelligent multilingual voice AI agents in the UAE. These agents support multiple industries, including healthcare, with 24/7 natural, human-like communication in over 30 languages, including Arabic dialects. The AI agents enable appointment booking, medication reminders, and basic triage assistance, integrating with CRM and booking systems to automate front-line support while maintaining personalization.
In April 2025, Burjeel Holdings partnered with Hippocratic AI to deploy empathetic generative AI healthcare agents across its network in the UAE, Oman, and Saudi Arabia.
Report Attribute
Details
Market size value in 2025
USD 222.53 million
Revenue forecast in 2033
USD 1,110.56 million
Growth rate
CAGR of 22.26% from 2025 to 2033
Actual data
2021 – 2023
Forecast period
2025 – 2033
Quantitative units
Revenue in USD million and CAGR from 2025 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Delivery mode, functionality, technology, therapeutic area, end use, and region
Regional scope
Middle East
Country scope
Saudi Arabia, UAE, Qatar, Oman, and Kuwait
Key companies profiled
Oracle; IQVIA Inc; Innovaccer, Inc.; UST; Huma; Ada Health GmbH; AiCure
Customization scope
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East AI in patient engagement market report based on delivery mode, functionality, technology, therapeutic area, end use, and country:
Delivery Mode Outlook (Revenue, USD Million, 2021 – 2033)
Cloud-based
On-premise
Functionality Outlook (Revenue, USD Million, 2021 – 2033)
Enhanced Communication
Patient Education
Chatbots and Virtual Health Assistants
Predictive Analytics
Administrative and Streamlined Operations
Others
Technology Outlook (Revenue, USD Million, 2021 – 2033)
Natural Language Processing (NLP)
Smart Assistance
OCR (Optical Character Recognition)
Auto Coding
Text Analytics
Speech Analytics
Classification and Categorization
Others
Therapeutic Area Outlook (Revenue, USD Million, 2021 – 2033)
Health & Wellness
Chronic Disease Management
Others
End Use Outlook (Revenue, USD Million, 2021 – 2033)
Healthcare Providers
Healthcare Payers
Pharmaceutical Companies
Pharmacy
Country Outlook (Revenue, USD Million, 2021 – 2033)
Saudi Arabia
UAE
Kuwait
Qatar
Oman
b. The Middle East AI in patient engagement market size was estimated at USD 183.53 million in 2024 and is expected to reach USD 222.53 million in 2025.
b. The Middle East AI in patient engagement market is expected to grow at a compound annual growth rate of 22.26% from 2025 to 2033 to reach USD 1,110.56 million by 2033.
b. Cloud-based segment dominated the Middle East AI in patient engagement market with a share of 77.65% in 2024.
b. Some key players operating in the Middle East AI in patient engagement market include Oracle; IQVIA Inc; Innovaccer, Inc.; UST; Huma; Ada Health GmbH; AiCure.
b. Key factors that are driving the Middle East AI in patient engagement market growth include rapid expansion of digital health infrastructure, coupled with integration of artificial intelligence (AI) in healthcare, growing adoption of telemedicine and remote care, and increasing government investments.
We never share your personal data. Privacy Policy
45% of our reports are customized. Tailor this report to your needs; reach out to us.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
“The quality of research they have done for us has been excellent.”
Grand View Research is registered in the State of California at Grand View Research, Inc. 201 Spear Street 1100, San Francisco, CA 94105, United States
+1-415-349-0058 or 1-888-202-9519
[email protected]
Our support available to help you 24 hours a day, five days a week.
Copyright © 2025 Grand View Research, Inc. All rights reserved.
We never share your personal data. Privacy Policy
